We are live on ! Find out more
VFA

Virtus Fund Advisers Portfolio holdings

AUM $32.1M
1-Year Est. Return 39.5%
This Fund
S&P 500
This Quarter Est. Return
+5.84%
1 Year Est. Return
+39.5%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$10.2B
AUM Growth
+$370M
Cap. Flow
-$141M
Cap. Flow %
-1.39%
Top 10 Hldgs %
14%
Holding
622
New
136
Increased
89
Reduced
249
Closed
24

Top Buys

Rank Stock Value
1
RSG icon
Republic Services
RSG
+$92.7M
2
FRC
First Republic Bank
FRC
+$73.7M
3
BP icon
BP
BP
+$67.2M
4
KHC icon
Kraft Heinz
KHC
+$62.4M
5
HUM icon
Humana
HUM
+$56.3M

Sector Composition

Rank Sector Weight
1 Financials 16.41%
2 Industrials 15.8%
3 Healthcare 10.6%
4 Technology 10.4%
5 Energy 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SSD icon
426
Simpson Manufacturing
SSD
$7.03B
$337K ﹤0.01%
5,872
-3,347
-36% -$185K
AVEO
427
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$337K ﹤0.01%
+12,065
New +$375K
BLD
428
DELISTED
TopBuild
BLD
$336K ﹤0.01%
4,435
-375
-8% -$24.9K
LUMO
429
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$336K ﹤0.01%
+4,608
New +$381K
AKAO
430
DELISTED
Achaogen Inc
AKAO
$336K ﹤0.01%
+31,243
New +$392K
ITCI
431
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$335K ﹤0.01%
+23,102
New +$357K
IDTI
432
DELISTED
Integrated Device Technology I
IDTI
$335K ﹤0.01%
11,265
-2,881
-20% -$86.6K
INO icon
433
Inovio Pharmaceuticals
INO
$122M
$334K ﹤0.01%
+6,738
New +$418K
SUPN icon
434
Supernus Pharmaceuticals
SUPN
$2.41B
$333K ﹤0.01%
8,355
-709
-8% -$28K
ATNX
435
DELISTED
Athenex, Inc. Common Stock
ATNX
$333K ﹤0.01%
+1,047
New +$358K
GDX icon
436
VanEck Gold Miners ETF
GDX
$28.3B
$331K ﹤0.01%
+14,230
New +$324K
MXL icon
437
MaxLinear
MXL
$5.88B
$330K ﹤0.01%
12,480
-6,598
-35% -$165K
NVAX icon
438
Novavax
NVAX
$1.58B
$329K ﹤0.01%
+13,260
New +$324K
SCL icon
439
Stepan Co
SCL
$1.39B
$327K ﹤0.01%
4,135
-350
-8% -$28.7K
BA icon
440
Boeing
BA
$166B
$325K ﹤0.01%
1,103
IOVA icon
441
Iovance Biotherapeutics
IOVA
$4.19B
$322K ﹤0.01%
+40,259
New +$323K
KDNY
442
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$321K ﹤0.01%
+8,547
New +$373K
AGEN
443
Agenus
AGEN
$321M
$320K ﹤0.01%
+5,006
New +$382K
DOVA
444
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
$318K ﹤0.01%
+11,044
New +$303K
GERN icon
445
Geron
GERN
$880M
$314K ﹤0.01%
+174,683
New +$353K
AKCA
446
DELISTED
Akcea Therapeutics Inc
AKCA
$314K ﹤0.01%
+18,071
New +$354K
VSAT icon
447
Viasat
VSAT
$9.87B
$312K ﹤0.01%
4,169
-353
-8% -$24.5K
MRNS
448
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$308K ﹤0.01%
+9,451
New +$255K
ABCB icon
449
Ameris Bancorp
ABCB
$5.69B
$306K ﹤0.01%
6,334
+1,078
+21% +$52.2K
MRK icon
450
Merck
MRK
$357B
$305K ﹤0.01%
5,641

Similar funds

Virtus Fund Advisers's Q4 2017 Portfolio in Review

As of Q4 2017, Virtus Fund Advisers held 622 positions worth $10.2B, up 3.8% from $9.81B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Virtus Fund Advisers's Q4 2017 filing shows 136 new, 89 increased, 249 reduced and 24 closed positions. Its largest new stake was BP: 1,855,977 shares worth $71.4M. The largest sale was Edison International, an estimated $74.9M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Industrials and Healthcare.

  • Virtus Fund Advisers's largest Q4 2017 buy was BP: 1,855,977 shares worth $71.4M.
  • Virtus Fund Advisers added most to Republic Services in Q4 2017, an estimated $92.7M increase.
  • Virtus Fund Advisers's biggest Q4 2017 reduction was Public Storage, cutting an estimated $53.8M.
  • Virtus Fund Advisers fully exited Edison International in Q4 2017, selling an estimated $74.9M.
  • Virtus Fund Advisers's ten largest holdings make up 14% of its $10.2B portfolio in Q4 2017.
  • Virtus Fund Advisers opened 136 new positions and closed 24 in Q4 2017.
  • Virtus Fund Advisers's portfolio value rose 3.8% quarter-over-quarter to $10.2B.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.